Proposed FDA Generic Drug Labeling Policy Questioned

被引：0
|
作者：
不详
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 311卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1005 / 1005
页数：1
相关论文
共 50 条
  • [1] FDA defends generic drug labeling plan
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (10) : 770 - +
  • [2] AN ADVERSE REACTION: FDA REGULATION OF GENERIC DRUG LABELING
    Stern, Mitchell Russell
    NEW YORK UNIVERSITY LAW REVIEW, 2015, 90 (06) : 2154 - 2190
  • [3] FDA CONSIDERS DRUG LABELING
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 1960, 263 (10): : 513 - 513
  • [4] Overview of FDA Drug Approval and Labeling
    Clarridge, Katherine E.
    Chin, Stacy J.
    Stone, Kelly D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3051 - 3056
  • [5] FDA oversight questioned
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (22): : 2611 - 2611
  • [6] FDA AUTHORITY QUESTIONED
    DAVID, NF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (20): : 2191 - 2191
  • [7] FDA downsizing questioned
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (14): : 1631 - 1631
  • [8] LABELING PRESCRIPTIONS WITH GENERIC DRUG NAMES
    PARKER, WA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (01): : 38 - 38
  • [9] DIGOXIN BIOAVAILABILITY - EVALUATION OF A GENERIC TABLET AND PROPOSED FDA GUIDELINES
    KRAMER, WG
    KOLIBASH, AJ
    BATHALA, MS
    VISCONTI, JA
    LEWIS, RP
    REUNING, RH
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (12) : 1720 - 1722
  • [10] FDA POLICY ON THE USE OF DATABASES FOR NUTRITION LABELING
    SCARBROUGH, FE
    BENDER, MM
    FOOD TECHNOLOGY, 1995, 49 (05) : 142 - 145
12345